Continuing Our Commitment To Being Different

When ProStrakan laid down roots in the US, we made a commitment to address the unmet needs of oncology patients and the healthcare professionals who care for them.

Today, those roots are stronger than ever as we continue to make a difference with SANCUSO® (Granisetron Transdermal System), a treatment for chemotherapy induced nausea and vomiting (CINV), and a Fareston2 (toremifene citrate) 60 mg Tablets, a treatment for metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumors.